Table 2 Antibody responses to L523S in lung cancer patients

From: L523S, an RNA-binding protein as a potential therapeutic target for lung cancer

Lung pleural effusion from patients

Responses to BSA

Responses to L523S

1

−

−

2

−

−

3

−

−

4

−

++

5

−

++

6

−

−

7

−

+++

8

−

++

9

−

++

10

−

+++

11

−

−

12

−

+++

13

−

−

14

−

−

15

−

++

16

−

−

17

−

−

48 sera from nomal donors

 

−

  1. The data are derived from ELISA. The specificity of the antibody response in each ELISA-positive sample was also confirmed by Western blot analysis. ‘++’ Indicates that Western blot result was obtained with more than 30-fold dilution of LPE, whereas ‘+++’ denotes immunoreactivity by Western blot with more than 300-fold dilution of the LPE samples.